BERBEVIS
LIVE

Serial Number

79319375

Owner

INDENA, S.P.A.

Attorney

Robert S. Broder

Filing Date

Jul 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BERBEVIS Trademark

Serial Number: 79319375 • Registration: 6897582

BERBEVIS is a trademark filed by INDENA, S.P.A. on July 15, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

INDENA, S.P.A. (163 trademarks)

MILAN , IT

Entity Type: 03

Trademark Details

Filing Date

July 15, 2021

Registration Date

November 15, 2022

Published for Opposition

August 30, 2022

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 27, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 14, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 5, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 9, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 9, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 15, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 15, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 15, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 29, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 29, 2022 TROA
REFUSAL PROCESSED BY IB
May 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 9, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 8, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 8, 2022 RFCR
NON-FINAL ACTION WRITTEN
Apr 7, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Apr 1, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 27, 2021 NREP
APPLICATION FILING RECEIPT MAILED
Sep 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 2, 2021 REPR